Delivery Order SPE2DB24D2106-SPE2DB25FAVVL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,330.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra 30 mg/ml syringes. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and was executed on July 22, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was awarded a delivery order valued at $2,275.00 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Fasenra Pen 30 mg/ml. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, with performance taking place in Conshohocken, Pennsylvania. The award was made without a set-aside designation, allowing the vendor to compete on an unrestricted basis in...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,548.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra 30 mg/ml syringes. The award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing under its existing single-award Indefinite Delivery Contract with DLA's...
- The Defense Logistics Agency awarded a $19,548 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Fasenra 30 mg/ml syringes, with an ultimate completion date of September 19, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the contractor's Park Ridge facility and represents a discrete purchase under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $2,275.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA Pen 30 mg/ml. The delivery order, which became effective on September 5, 2025, with an ultimate completion date of September 26, 2025, will be performed in Conshohocken, Pennsylvania. This award was made without a set-aside designation, allowing the contractor to compete directly in the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,887.00 by the Defense Logistics Agency (DLA) on August 27, 2025. The contract calls for the delivery of Fasenra 30 mg/ml syringes, a biologic medication used in the treatment of severe eosinophilic asthma. The award carries no set-aside designation and has an ultimate completion date of August 28, 2025, with performance...
- This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,446.80 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on June 7, 2024 and runs through June 10, 2024. The award is for the provision of Fasenra Pen 30 mg/mL medication to support the medical supply needs of military health facilities. This order is issued under DMS Pharmaceutical Group's single-award indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,443.50 firm fixed-price contract is for the supply of Fasenra 30mg/mL syringe, a biologic drug used to treat severe asthma. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,443.50 order is for the provision of Fasenra 30 mg/mL syringes, with a period of performance through January 31, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,275.00 to DMS Pharmaceutical Group Inc. for FASENRA PEN 30 MG/ML, a pharmaceutical product used in the treatment of severe asthma. The award was issued on August 5, 2025, with an ultimate completion date of August 26, 2025, with performance taking place in Conshohocken, Pennsylvania. This delivery order does not utilize any set-aside designation and represents a single transaction under DMS Pharmaceutical Group's...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAVVLDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $2,275.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of August 14, 2025, is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The delivery order carries no set-aside designation and will be performed in Conshohocken, Pennsylvania. Fasenra is a biologic medication used in the treatment of eosinophilic asthma and other eosinophilic conditions. As a key supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its IDC with the Defense Logistics Agency to fulfill firm fixed-price delivery orders supporting the medical supply needs of Department of Defense healthcare facilities worldwide. This delivery order exemplifies the company's role in providing specialized pharmaceutical products, including biologics and injections, directly to military health systems across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/24/25 |